177 related articles for article (PubMed ID: 15135215)
1. Developing drugs for pediatric use: a role for juvenile animal studies?
Baldrick P
Regul Toxicol Pharmacol; 2004 Jun; 39(3):381-9. PubMed ID: 15135215
[TBL] [Abstract][Full Text] [Related]
2. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages.
Brent RL
Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806
[TBL] [Abstract][Full Text] [Related]
3. Juvenile animal testing in drug development--is it useful?
Baldrick P
Regul Toxicol Pharmacol; 2010; 57(2-3):291-9. PubMed ID: 20350578
[TBL] [Abstract][Full Text] [Related]
4. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of juvenile toxicity.
Barrow PC; Barbellion S; Stadler J
Methods Mol Biol; 2011; 691():17-35. PubMed ID: 20972745
[TBL] [Abstract][Full Text] [Related]
6. Role of biokinetics in risk assessment of drugs and chemicals in children.
de Zwart LL; Haenen HE; Versantvoort CH; Wolterink G; van Engelen JG; Sips AJ
Regul Toxicol Pharmacol; 2004 Jun; 39(3):282-309. PubMed ID: 15135209
[TBL] [Abstract][Full Text] [Related]
7. Juvenile animal toxicity study designs to support pediatric drug development.
Cappon GD; Bailey GP; Buschmann J; Feuston MH; Fisher JE; Hew KW; Hoberman AM; Ooshima Y; Stump DG; Hurtt ME
Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):463-9. PubMed ID: 20025047
[TBL] [Abstract][Full Text] [Related]
8. [Are children getting the right drugs?].
Bratlid D
Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3290-2. PubMed ID: 16327857
[TBL] [Abstract][Full Text] [Related]
9. Use of anesthetic agents in neonates and young children.
Mellon RD; Simone AF; Rappaport BA
Anesth Analg; 2007 Mar; 104(3):509-20. PubMed ID: 17312200
[TBL] [Abstract][Full Text] [Related]
10. The value of juvenile animal studies: a Japanese industry perspective.
Shimomura K
Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):266-8. PubMed ID: 21594974
[TBL] [Abstract][Full Text] [Related]
11. Juvenile animal studies and pediatric drug development: a European regulatory perspective.
Carleer J; Karres J
Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):254-60. PubMed ID: 21638754
[TBL] [Abstract][Full Text] [Related]
12. The value of juvenile animal studies: a pediatric clinical perspective.
Rose K
Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):252-3. PubMed ID: 21594978
[TBL] [Abstract][Full Text] [Related]
13. First dose of potential new medicines to humans: how animals help.
Greaves P; Williams A; Eve M
Nat Rev Drug Discov; 2004 Mar; 3(3):226-36. PubMed ID: 15031736
[TBL] [Abstract][Full Text] [Related]
14. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
Box RJ; Spielmann H
Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
[TBL] [Abstract][Full Text] [Related]
15. Applications of accelerator MS in pediatric drug evaluation.
Vuong LT; Blood AB; Vogel JS; Anderson ME; Goldstein B
Bioanalysis; 2012 Aug; 4(15):1871-82. PubMed ID: 22943618
[TBL] [Abstract][Full Text] [Related]
16. Real life juvenile toxicity case studies: the good, the bad and the ugly.
De Schaepdrijver L; Rouan MC; Raoof A; Bailey GP; De Zwart L; Monbaliu J; Coogan TP; Lammens L; Coussement W
Reprod Toxicol; 2008 Sep; 26(1):54-5. PubMed ID: 18514481
[TBL] [Abstract][Full Text] [Related]
17. Direct dosing of preweaning rodents in toxicity testing and research: deliberations of an ILSI RSI Expert Working Group.
Moser VC; Walls I; Zoetis T
Int J Toxicol; 2005; 24(2):87-94. PubMed ID: 16036767
[TBL] [Abstract][Full Text] [Related]
18. The timing of preclinical toxicological studies: pharmaceutical company approaches to toxicity testing in support of initial clinical investigations.
Parkinson C; Thomas KE; Lumley CE
Regul Toxicol Pharmacol; 1996 Apr; 23(2):162-72. PubMed ID: 8661335
[TBL] [Abstract][Full Text] [Related]
19. The need for juvenile animal studies--a critical review.
Soellner L; Olejniczak K
Regul Toxicol Pharmacol; 2013 Feb; 65(1):87-99. PubMed ID: 23108189
[TBL] [Abstract][Full Text] [Related]
20. Stimulation programs for pediatric drug research--do children really benefit?
Boots I; Sukhai RN; Klein RH; Holl RA; Wit JM; Cohen AF; Burggraaf J
Eur J Pediatr; 2007 Aug; 166(8):849-55. PubMed ID: 17225950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
